128 related articles for article (PubMed ID: 20974615)
1. Osteoprotegerin genetic polymorphisms and age of symptom onset in ankylosing spondylitis.
Huang CH; Wei JC; Hung PS; Shiu LJ; Tsay MD; Wong RH; Lee HS
Rheumatology (Oxford); 2011 Feb; 50(2):359-65. PubMed ID: 20974615
[TBL] [Abstract][Full Text] [Related]
2. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
[TBL] [Abstract][Full Text] [Related]
3. The HLA-B27 transgenic rat, a model of spondyloarthritis, has decreased bone mineral density and increased RANKL to osteoprotegerin mRNA ratio.
Rauner M; Stupphann D; Haas M; Fert I; Glatigny S; Sipos W; Breban M; Pietschmann P
J Rheumatol; 2009 Jan; 36(1):120-6. PubMed ID: 19040304
[TBL] [Abstract][Full Text] [Related]
4. Genetic variations in genes encoding RANK, RANKL, and OPG in rheumatoid arthritis: a case-control study.
Assmann G; Koenig J; Pfreundschuh M; Epplen JT; Kekow J; Roemer K; Wieczorek S
J Rheumatol; 2010 May; 37(5):900-4. PubMed ID: 20231205
[TBL] [Abstract][Full Text] [Related]
5. Association of Genetic Variants of
Wang CM; Tsai SC; Lin JC; Wu YJ; Wu J; Chen JY
Mediators Inflamm; 2019; 2019():8029863. PubMed ID: 31015798
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of RANK/RANKL/OPG gene polymorphisms in aggressive periodontitis.
Soedarsono N; Rabello D; Kamei H; Fuma D; Ishihara Y; Suzuki M; Noguchi T; Sakaki Y; Yamaguchi A; Kojima T
J Periodontal Res; 2006 Oct; 41(5):397-404. PubMed ID: 16953816
[TBL] [Abstract][Full Text] [Related]
7. The effects of osteoprotegerin (OPG) gene polymorphism in patients with ischaemic heart disease on the morphology of coronary arteries and bone mineral density.
Celczyńska Bajew L; Horst Sikorska W; Bychowiec B; Wykrętowicz A; Wesoły J; Michalak M
Kardiol Pol; 2011; 69(6):573-8. PubMed ID: 21678294
[TBL] [Abstract][Full Text] [Related]
8. Osteoprotegerin (OPG)/RANK-L system in juvenile idiopathic arthritis: is there a potential modulating role for OPG/RANK-L in bone injury?
Masi L; Simonini G; Piscitelli E; Del Monte F; Giani T; Cimaz R; Vierucci S; Brandi ML; Falcini F
J Rheumatol; 2004 May; 31(5):986-91. PubMed ID: 15124262
[TBL] [Abstract][Full Text] [Related]
9. Changes of serum levels of MMP-3, sRANKL, and OPG in juvenile-onset ankylosing spondylitis patients carrying different HLA-B27 subtypes.
Mou YK; Zhang PP; Li QX; Lin ZM; Liao ZT; Wei QJ; Gu JR
Clin Rheumatol; 2015 Jun; 34(6):1085-9. PubMed ID: 25912212
[TBL] [Abstract][Full Text] [Related]
10. TNF-238A promoter polymorphism contributes to susceptibility to ankylosing spondylitis in HLA-B27 negative patients.
González S; Torre-Alonso JC; Martínez-Borra J; Fernández Sánchez JA; López-Vazquez A; Rodríguez Pérez A; López-Larrea C
J Rheumatol; 2001 Jun; 28(6):1288-93. PubMed ID: 11409121
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures.
Langdahl BL; Carstens M; Stenkjaer L; Eriksen EF
J Bone Miner Res; 2002 Jul; 17(7):1245-55. PubMed ID: 12096838
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of OPG, RANK, and ESR1 and bone mineral density in Korean postmenopausal women.
Choi JY; Shin A; Park SK; Chung HW; Cho SI; Shin CS; Kim H; Lee KM; Lee KH; Kang C; Cho DY; Kang D
Calcif Tissue Int; 2005 Sep; 77(3):152-9. PubMed ID: 16151677
[TBL] [Abstract][Full Text] [Related]
13. Interaction between RANKL and HLA-DRB1 genotypes may contribute to younger age at onset of seropositive rheumatoid arthritis in an inception cohort.
Wu H; Khanna D; Park G; Gersuk V; Nepom GT; Wong WK; Paulus HE; Tsao BP
Arthritis Rheum; 2004 Oct; 50(10):3093-103. PubMed ID: 15476205
[TBL] [Abstract][Full Text] [Related]
14. Osteoprotegerin/RANKL system imbalance in active polyarticular-onset juvenile idiopathic arthritis: a bone damage biomarker?
Spelling P; Bonfá E; Caparbo VF; Pereira RM
Scand J Rheumatol; 2008; 37(6):439-44. PubMed ID: 18802807
[TBL] [Abstract][Full Text] [Related]
15. Circulating amounts of osteoprotegerin and RANK ligand: genetic influence and relationship with BMD assessed in female twins.
Abrahamsen B; Hjelmborg JV; Kostenuik P; Stilgren LS; Kyvik K; Adamu S; Brixen K; Langdahl BL
Bone; 2005 Apr; 36(4):727-35. PubMed ID: 15781001
[TBL] [Abstract][Full Text] [Related]
16. TLR4 mutations (Asp299Gly and Thr399Ile) are not associated with ankylosing spondylitis.
Adam R; Sturrock RD; Gracie JA
Ann Rheum Dis; 2006 Aug; 65(8):1099-101. PubMed ID: 16837493
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the gene polymorphism of osteoprotegerin and bone mineral density in hemodialysis patients.
Yin LL; Jing N; Zhao ZY; Liu XH; Du J; Qin LL; Song JG; Xu Y
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):37-41. PubMed ID: 28121359
[TBL] [Abstract][Full Text] [Related]
18. RANKL:osteoprotegerin ratio and bone mineral density in children with untreated juvenile dermatomyositis.
Rouster-Stevens KA; Langman CB; Price HE; Seshadri R; Shore RM; Abbott K; Pachman LM
Arthritis Rheum; 2007 Mar; 56(3):977-83. PubMed ID: 17328075
[TBL] [Abstract][Full Text] [Related]
19. HLA-B27 polymorphism in patients with juvenile and adult-onset ankylosing spondylitis in Southern China.
Mou Y; Wu Z; Gu J; Liao Z; Lin Z; Wei Q; Huang J; Li Q
Tissue Antigens; 2010 Jan; 75(1):56-60. PubMed ID: 20196819
[TBL] [Abstract][Full Text] [Related]
20. Biology of RANK, RANKL, and osteoprotegerin.
Boyce BF; Xing L
Arthritis Res Ther; 2007; 9 Suppl 1(Suppl 1):S1. PubMed ID: 17634140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
